Johnson & Johnson

The staff who were present had the opportunity to choose between the Johnson and Johnson vaccine or AstraZeneca vaccine.

The Speaker of Parliament Job Pomat and several staff from the Speaker’s office also received the COVID-19 vaccination.

Mr Pomat said he opted for the Johnson and Johnson vaccine, and he would like to see more people come forward to be vaccinated. He stressed that the staff are not forced to be vaccinated but emphasized that vaccination is an individual’s choice.

The case, expected to last six months, will involve women who claim their lives have been ruined by a vaginal medical device made by Johnson & Johnson.

It is designed to treat common complications from childbirth.

The firm behind the class action, Shine Lawyers, claimed about 8000 women could have been affected by mesh and tape surgical implants used to fix pelvic-floor damage from prolapse and incontinence.

The true number of Australia women affected is the subject of a senate inquiry. Estimates range from 3000 to 30,000 women.

The firm said the vulnerability concerned its OneTouch Ping pump which is only sold in the US and Canada.

However, it told the BBC there had been no reported attacks and the risk was "extremely low".

"It would require technical expertise, sophisticated equipment and proximity to the pump," it said.

The disclosure was made in a letter to patients on 27 September, the firm said.